Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
27,913,643
-
Share change
-
+2,772,155
-
Total reported value
-
$1,783,489,511
-
Put/Call ratio
-
65%
-
Price per share
-
$63.91
-
Number of holders
-
198
-
Value change
-
+$178,377,572
-
Number of buys
-
100
-
Number of sells
-
70
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q3 2015
As of 30 Sep 2015,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
198 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,913,643 shares.
The largest 10 holders included
Fisher Asset Management, LLC, AQR CAPITAL MANAGEMENT LLC, COMMONWEALTH BANK OF AUSTRALIA, VANGUARD GROUP INC, BlackRock Group LTD, SCHRODER INVESTMENT MANAGEMENT GROUP, BlackRock Institutional Trust Company, N.A., ACADIAN ASSET MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, and Origin Asset Management LLP.
This page lists
199
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.